These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23911194)

  • 1. Insulin pump therapy in children with type 1 diabetes: the dark side of the moon.
    Scaramuzza AE; Dell'Acqua M; Macedoni M; Zuccotti GV
    J Diabetes Sci Technol; 2013 Jul; 7(4):1095-7. PubMed ID: 23911194
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type.
    Ross P; Gray AR; Milburn J; Kumarasamy IM; Wu F; Farrand S; Armishaw J; Wiltshire E; Rayns J; Tomlinson P; Wheeler BJ
    Acta Diabetol; 2016 Dec; 53(6):991-998. PubMed ID: 27585938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
    Dogan ADA; Jørgensen UL; Gjessing HJ
    J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin pumps.
    Torrance T; Franklin V; Greene S
    Arch Dis Child; 2003 Nov; 88(11):949-53. PubMed ID: 14612350
    [No Abstract]   [Full Text] [Related]  

  • 5. Variability of Basal Rate Profiles in Insulin Pump Therapy and Association with Complications in Type 1 Diabetes Mellitus.
    Laimer M; Melmer A; Mader JK; Schütz-Fuhrmann I; Engels HR; Götz G; Pfeifer M; Hermann JM; Stettler C; Holl RW
    PLoS One; 2016; 11(3):e0150604. PubMed ID: 26938444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic control and treatment satisfaction in Saudi diabetic children on insulin pump therapy.
    Bin-Abbas BS; Sakati NA; Al-Ashwal AA
    Ann Saudi Med; 2006; 26(5):405. PubMed ID: 17120382
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ketoacidosis during insulin pump therapy--an acceptable risk?].
    Walter H; Mehnert H
    Dtsch Med Wochenschr; 1989 May; 114(18):722-5. PubMed ID: 2496966
    [No Abstract]   [Full Text] [Related]  

  • 9. In-hospital management of adults using insulin pump therapy.
    Houlden RL; Moore S
    Can J Diabetes; 2014 Apr; 38(2):126-33. PubMed ID: 24690507
    [No Abstract]   [Full Text] [Related]  

  • 10. Problems and safety of continuous subcutaneous insulin infusion.
    Home PD; Marshall SM
    Diabet Med; 1984 May; 1(1):41-4. PubMed ID: 6242775
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetic ketoacidosis caused by exposure of insulin pump to heat and sunlight.
    Pryce R
    BMJ; 2009 Jan; 338():a2218. PubMed ID: 19124546
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk and Relevance of Insulin Pump Therapy in the Aetiology of Ketoacidosis in People with Type 1 Diabetes.
    Giessmann LC; Kann PH
    Exp Clin Endocrinol Diabetes; 2020 Nov; 128(11):745-751. PubMed ID: 30049002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin pump breakdown and infusion set failure in Italian children with type 1 diabetes: A 1-year prospective observational study with suggestions to minimize clinical impact.
    Rabbone I; Minuto N; Toni S; Lombardo F; Iafusco D; Marigliano M; Schiaffini R; Maltoni G; Frongia AP; Scardapane M; Nicolucci A; Cherubini V; Bonfanti R; Scaramuzza AE;
    Diabetes Obes Metab; 2018 Nov; 20(11):2551-2556. PubMed ID: 29893044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported experience with Velosulin human insulin in continuous subcutaneous insulin infusion.
    Marcus A; Bode B; Drexler A; Etkind E; Koch MM; Liljenquist JE; McCulloch DK; Strowig SM; Tanenberg RJ
    Clin Ther; 1995; 17(2):204-13. PubMed ID: 7614521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin pump treatment: For whom and how to set it up on an outpatient?].
    Mbundu Ilunga R; Camponovo C; Le Dizès O; Wojtusciszyn A
    Rev Med Suisse; 2020 Jun; 16(697):1191-1196. PubMed ID: 32520457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data.
    Kjærulff MLBG; Astrup BS
    J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
    Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
    Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
    Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with insulin pump during hospital care should be questioned. Three cases illustrate the risk of ketoacidosis].
    Gubrianska D; Moberg E; Palmér M
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1967-8. PubMed ID: 19764373
    [No Abstract]   [Full Text] [Related]  

  • 20. Prime-time hypoglycemia: factitious hypoglycemia during insulin-pump therapy.
    Osipoff JN; Sattar N; Garcia M; Wilson TA
    Pediatrics; 2010 May; 125(5):e1246-8. PubMed ID: 20385648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.